The use of selective PDE inhibitors has been proven to be useful in the clinic, particularly PDE5 inhibitors, which are drugs used to treat erectile dysfunction and pulmonary arterial hypertension [164–166]. This evidence concerns the gene PDE5A and erectile dysfunction.